Socioeconomically disadvantaged people still underusing emergency department services in the wake of the COVID pandemic
Peer-Reviewed Publication
Updates every hour. Last Updated: 24-Jul-2025 03:11 ET (24-Jul-2025 07:11 GMT/UTC)
Socioeconomically disadvantaged groups may still be underusing emergency departments for potentially serious illnesses in the wake of the COVID pandemic, despite an overall rebound in emergency department use by 2022. Most of the rebound had been driven primarily by patients covered by commercial insurance or Medicare fee-for-service. When stratified by insurance type, however, the rebound was found to be significantly lower among patients covered by Medicaid or dual Medicare/Medicaid, who tend to be socioeconomically disadvantaged.
A new study published in the Journal of Substance Use and Addiction Treatment examined federal data on health and drug use among nearly 20,000 people who inject drugs and are low-income in the US, and found no association between Medicaid expansion and misuse of prescription opioids or benzodiazepines, drugs often prescribed for anxiety or insomnia. These findings present real-world data that disprove narratives claiming that Medicaid expansion has fueled the longstanding opioid crisis in America by increasing access to low-cost prescription opioids diverted for non-prescribed use.
A unique analysis of district-level data reveals why inequality is so destructive to the household consumption welfare of people living below the poverty line. During negative economic growth, the welfare of the poor should be the main focus area.
Empire Discovery Institute (EDI), a leading non-profit drug discovery and development accelerator, is pleased to announce the appointment of Dr. Ronald Newbold as Chief Executive Officer (CEO). Dr. Newbold, who joined EDI in 2021 as Chief Business Officer, has served as interim CEO since August 2022 and has been instrumental in driving the organization’s growth and success.